University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Elyse Foster, M.D.

Director of adult Echocardiography and Congenital Heart Disease

Dr. Elyse Foster is director of the UCSF Adult Echocardiography Laboratory and Adult Congenital Heart Disease Service. She specializes in the assessment of cardiac function using echocardiography, including exercise and pharmacologic stress testing for ischemia detection. She also has a special interest in adult congenital heart conditions and valvular disease.

Foster earned a medical degree at Tufts University School of Medicine. She completed a residency in internal medicine at Boston Medical Center, where she also completed a fellowship in cardiovascular diseases. Foster is on the executive committee of the International Society of Adult Congenital Heart Disease and is on the Women in Cardiology Committee for the American College of Cardiology. She is board certified in both internal medicine and cardiovascular disease.

Clinics

Cardiovascular Care and Prevention Center at Mission Bay
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Cardiovascular Genetics Program
400 Parnassus Avenue, Plaza Level, Room 94
San Francisco, CA 94143
Phone: (415) 353-2873
Fax: (415) 476-5355

Hours: Monday
noon – 4 p.m

Congenital Heart Disease Clinic
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-8687

Hours: Monday and Tuesday
8:30 a.m. – 4:30 p.m.

Thursday
1 – 4:30 p.m.

ECG/ Stress Testing/ Nuclear Cardiology Laboratories at Parnassus
505 Parnassus Ave., Suite M-344
San Francisco, CA 94143
Phone: (415) 353-1931
Fax: (415) 353-8675

Hours: Monday to Friday
8:30 a.m. – 5 p.m

Echocardiography Lab at Mount Zion
1600 Divisadero St., Second Floor
San Francisco, CA 94115
Phone: (415) 885-7321
Fax: (415) 885-7849

Hours: Monday
1 p.m. – 5 p.m.

Tuesday
8a.m. – 12 p.m.

Wednesday and Friday
9 a.m. – 5 p.m.

Thursday
8 a.m. – 4:40 p.m.

Echocardiography Lab at Parnassus
505 Parnassus Ave., Suite M344
San Francisco, CA 94143
Phone: (415) 353-1262
Fax: (415) 353-8675

Hours: Monday to Friday
8:30 a.m. – 5 p.m.

Conditions & Treatments

More about Elyse Foster

Education

Tufts University School of Medicine 1977

Residencies

Boston Medical Center, Internal Medicine 1980

Fellowships

Boston Medical Center, Cardiovascular Diseases 1983

Selected Research and Publications

  1. Giglia TM, Massicotte MP, Tweddell JS, Barst RJ, Bauman M, Erickson CC, Feltes TF, Foster E, Hinoki K, Ichord RN, Kreutzer J, McCrindle BW, Newburger JW, Tabbutt S, Todd JL, Webb CL. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the american heart association. Circulation. 2013 Dec 17; 128(24):2622-703.
  2. Grayburn PA, Foster E, Sangli C, Weissman NJ, Massaro J, Glower DG, Feldman T, Mauri L. Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation. 2013 Oct 8; 128(15):1667-74.
  3. Kohi MP, Ordovas KG, Naeger DM, Meadows AK, Foster E, Higgins CB. CMR assessment of right ventricular function in patients with combined pulmonary stenosis and insufficiency after correction of tetralogy of Fallot. Acta Radiol. 2013 Dec 1; 54(10):1132-7.
  4. Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, Bajwa T, Lasala J, Low R, Grayburn P, Feldman T. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013 Jul 23; 62(4):317-28.
  5. Foster E, Kwan D, Feldman T, Weissman NJ, Grayburn PA, Schwartz A, Rogers JH, Kar S, Rinaldi MJ, Fail PS, Hermiller J, Whitlow PL, Herrmann HC, Lim DS, Glower DD. Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling. Circ Cardiovasc Imaging. 2013 Jul; 6(4):522-30.
  6. Rao RK, Foster E. Rethinking mitral valve surgery during the golden years. Circulation. 2013 May 7; 127(18):1843-6.
  7. Campbell P, Takeuchi M, Bourgoun M, Shah A, Foster E, Brown MW, Goldenberg I, Huang DT, McNitt S, Hall WJ, Moss A, Pfeffer MA, Solomon SD. Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy. Circ Heart Fail. 2013 May; 6(3):435-42.
  8. Armstrong EJ, Rogers JH, Swan CH, Upadhyaya D, Viloria E, McCulloch C, Slater J, Qureshi M, Williams J, Whisenant B, Feldman T, Foster E. Echocardiographic predictors of single versus dual MitraClip device implantation and long-term reduction of mitral regurgitation after percutaneous repair. Catheter Cardiovasc Interv. 2013 Oct 1; 82(4):673-9.
  9. Bansal N, Keane M, Delafontaine P, Dries D, Foster E, Gadegbeku CA, Go AS, Hamm LL, Kusek JW, Ojo AO, Rahman M, Tao K, Wright JT, Xie D, Hsu CY. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar; 8(3):355-62.
  10. Knappe D, Pouleur AC, Shah AM, Bourgoun M, Brown MW, Foster E, Pfeffer MA, Moss AJ, Solomon SD. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT. J Card Fail. 2013 Mar; 19(3):149-55.
  11. Bhave PD, Foster E, Dhaliwal G. Clinical problem-solving. A missed connection. N Engl J Med. 2012 Dec 6; 367(23):2241-7.
  12. Hope MD, Wrenn J, Sigovan M, Foster E, Tseng EE, Saloner D. Imaging biomarkers of aortic disease: increased growth rates with eccentric systolic flow. J Am Coll Cardiol. 2012 Jul 24; 60(4):356-7.
  13. Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol. 2012 Jun 19; 59(25):2366-73.
  14. Herrmann HC, Gertz ZM, Silvestry FE, Wiegers SE, Woo YJ, Hermiller J, Segar D, Heimansohn D, Gray W, Homma S, Argenziano M, Wang A, Jollis J, Lampert MB, Alexander J, Mauri L, Foster E, Glower D, Feldman T. Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol. 2012 Apr 3; 59(14):1312-9.
  15. Glower D, Ailawadi G, Argenziano M, Mack M, Trento A, Wang A, Lim DS, Gray W, Grayburn P, Dent J, Gillam L, Sethuraman B, Feldman T, Foster E, Mauri L, Kron I. EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg. 2012 Apr; 143(4 Suppl):S60-3.
  16. Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB, Foster E, Jaarsma T, Kloner RA, Lange RA, Lindau ST, Maron BJ, Moser DK, Ohman EM, Seftel AD, Stewart WJ. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012 Feb 28; 125(8):1058-72.
  17. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Herrmann HC, Lasala J, Maddux JT, Tuzcu M, Kapadia S, Trento A, Siegel RJ, Foster E, Glower D, Mauri L, Kar S. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol. 2012 Jan 10; 59(2):130-9.
  18. Rouine-Rapp K, Russell IA, Foster E. Congenital heart disease in the adult. Int Anesthesiol Clin. 2012; 50(2):16-39.
  19. Ordovas KG, Carlsson M, Lease KE, Foster E, Meadows AK, Martin AJ, Hope M, Do L, Higgins CB, Saeed M. Impaired regional left ventricular strain after repair of tetralogy of Fallot. J Magn Reson Imaging. 2012 Jan; 35(1):79-85.
  20. Brenyo A, Link MS, Barsheshet A, Moss AJ, Zareba W, Wang PJ, McNitt S, Huang D, Foster E, Estes M, Solomon SD, Goldenberg I. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011 Oct 11; 58(16):1682-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.